In this segment from Tuesday's Investor Beat, Motley Fool analyst Morgan Housel discusses the iShares NASDAQ Biotechnology Index (IBB 0.45%), and why he sees many tell-tale red flags that the biotech space is in a bubble right now. Morgan gives his insight on what these warning signs are, and whether or not the bubble could be near collapse.
